GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM
Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare tumors: tarlatamab trial opens
Disease control Recruiting nowThis study tests the drug tarlatamab in people with advanced tumors that have a protein called DLL3. The goal is to see if the drug can shrink or control these tumors. About 29 adults with stage IV cancer will receive tarlatamab, and researchers will track how well it works and a…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug MB0151 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called MB0151 in adults with advanced solid tumors, including certain lung, breast, and neuroendocrine cancers. The goal is to check the drug's safety and see if it can shrink or control tumors. About 156 participants will receive the drug intravenousl…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Mainline Biosciences (Shanghai) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC